Evidence map›Paper›PMID 25128174›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2014

Unexpected maturation of PI3K and MAPK-ERK signaling in fetal ovine cardiomyocytes.

N N Chattergoon, S Louey, P J Stork, G D Giraud, K L Thornburg

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Fetal cardiac troponin I levels decline toward birth in sheep.American journal of physiology. Heart and circulatory physiology · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Coronary vascular growth matches IGF-1-stimulated cardiac growth in fetal sheep.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. The programming of cardiovascular disease.Journal of developmental origins of health and disease · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

N N ChattergoonCenter for Developmental Health, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon; chatterg@ohsu.edu.
S LoueyCenter for Developmental Health, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon; Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, Oregon;
P J StorkCenter for Developmental Health, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon; Vollum Institute for Advanced Biomedical Research, Oregon Health and Science University, Portland, Oregon; and.
G D GiraudCenter for Developmental Health, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon; Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, Oregon; Portland Veterans Affairs Medical Center, Portland, Oregon.
K L ThornburgCenter for Developmental Health, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon; Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, Oregon;
Oregon Health & Science University · USPortland VA Medical Center · USVollum Institute · US

Funding

ULTRASOUND IMAGING COREP01HD034430 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI THOMAS, GEORGE VICTOR · 1997 to 2017
$20.7M
Cellular mechanisms of fetal white matter injuryR37NS045737 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI BACK, STEPHEN ARTHUR · 2007 to 2013
$2.7M
Thyroid regulation of cardiomyocyte maturationR01HL102763 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI THORNBURG, KENT L.R. · 2010 to 2013
$1.5M
Is thyroid hormone a key regulator of fetal cardiomyocyte proliferation?R21HL093617 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI THORNBURG, KENT L.R. · 2008 to 2009
$411k
NHLBI NIH HHS R01 HL102763NHLBI NIH HHS R01-HL-102763NHLBI NIH HHS R21 HL093617NICHD NIH HHS P01 HD034430NICHD NIH HHS P01-HD-34430NINDS NIH HHS R37-NS-045737
6 · The paper itself

Abstract

In the first two-thirds of gestation, ovine fetal cardiomyocytes undergo mitosis to increase cardiac mass and accommodate fetal growth. Thereafter, some myocytes continue to proliferate while others mature and terminally differentiate into binucleated cells. At term (145 days gestational age; dGA) about 60% of cardiomyocytes become binucleated and exit the cell cycle under hormonal control. Rising thyroid hormone (T3) levels near term (135 dGA) inhibit proliferation and stimulate maturation. However, the degree to which intracellular signaling patterns change with age in response to T3 is unknown. We hypothesized that in vitro activation of ERK, Akt, and p70(S6K) by two regulators of cardiomyocyte cell cycle activity, T3 and insulin like growth factor-1 (IGF-1), would be similar in cardiomyocytes at gestational ages 100 and 135 dGA. IGF-1 and T3 each independently stimulated phosphorylation of ERK, Akt, and p70(S6K) in cells at both ages. In the younger mononucleated myocytes, the phosphorylation of ERK and Akt was reduced in the presence of IGF-1 and T3. However, the same hormone combination led to a dramatic twofold increase in the phosphorylation of these signaling proteins in the 135 dGA cardiomyocytes-even in cells that were not proliferating. In the older cells, both mono- and binucleated cells were affected. In conclusion, fetal ovine cardiomyocytes undergo profound maturation-related changes in signaling in response to T3 and IGF-1, but not to either factor alone. Differences in age-related response are likely to be related to milestones in fetal cardiac development as the myocardium prepares for ex utero life.

Indexed as

MAP Kinase Signaling SystemAnimalsCell ProliferationCells, CulturedExtracellular Signal-Regulated MAP KinasesFetal HeartInsulin-Like Growth Factor IMyocytes, CardiacPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsProto-Oncogene Proteins c-aktRibosomal Protein S6 Kinases, 70-kDaSheepThyroid HormonesExtracellular Signal-Regulated MAP KinasesInsulin-Like Growth Factor IPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsProto-Oncogene Proteins c-aktRibosomal Protein S6 Kinases, 70-kDaThyroid Hormonescardiomyocyte proliferationfetal heartMAPKPI3Kthyroid hormone

Identifiers

PMID25128174
PMCPMC4200334
OpenAlexW2019261023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.